ALGS vs VICI · rev $3.6M vs P/E 9.3, rev $3.85B
Aligos Therapeutics Inc (ALGS) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
ALGS currently screens at market cap $44.1M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the ALGS and VICI stock pages for the full models.
Not investment advice.